
Japan’s car makers, Honda, Nissan, and Mitsubishi are having a go at bringing their operations together under a joint umbrella company, with Honda heading the new management. The merger is expected to go ahead in June. A merger could result in a behemoth worth more than $50 billion based on the market value of all three automakers. Together, Honda, Nissan, and Mitsubishi would gain significant enough market share to beat both Toyota and Germany’s troubled Volkswagen. Honda’s president, said that in order for all parties to be leaders in this transformation, it would be necessary to make bolder changes than just mere collaborations in specific areas. Nissan, Honda , and Mitsubishi earlier in 2024 agreed to share components for electric vehicles such as batteries, and to jointly research technology for self-driving vehicle designs. Most Read on Euro Weekly News Is sabotage behind new power cut? German island bans Christmas tradition of spanking women with cow horns! Digital human clones: Elon Musk’s AI empire expands as Grok sparks legal firestorm Three Japanese auto-manufacturing giants combine in one electric car behemoth Nissan has been struggling since a scandal that began with the arrest of its former chairman Carlos Ghosn in late 2018. Nissan has years of experience building batteries and electric vehicles, and gas-electric hybrid engines that could help Honda in developing its own EVs and next generation of hybrids. The company is not going through its best time and recently reshuffled management as well as taking a 50 precent pay cut while throwing hands in the air and admitting responsibility for its poor financial performance. The merger mirrors an industry-wide tendency towards consolidation and mergers, as Japanese companies need to keep up in an increasingly competitive and fast-changing market.
Business: Henry Schein is a solutions company for health care. It operates through two segments: health care distribution, and technology and value-added services. The health care distribution segment distributes an array of offerings, including consumable products, small equipment, laboratory products, large equipment and equipment repair services. The technology and value-added services segment provides software, technology and other services to health care practitioners. It offers dental practice management solutions for dental and medical practitioners. It also develops solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist). Activist Commentary: Ananym Capital Management is a New York-based activist investment firm which launched on Sept. 3. It's run by Charlie Penner (former partner at Jana Partners and head of shareholder activism at Engine No. 1) and Alex Silver (former partner and investment committee member at P2 Capital Partners). Ananym looks for high quality but undervalued companies, regardless of industry. The firm would prefer to work amicably with its portfolio companies, but it's willing to resort to a proxy fight as a last resort. It holds approximately 10 positions in its portfolio and currently manages $250 million. Henry Schein is a leading global distributor of health-care products and services primarily to office-based dental and medical practitioners. The company operates through two segments that offer different products and services to the same customer base: (i) health care distribution and (ii) technology and value-added services. Health care distribution covers Henry Schein's distribution of dental and medical products, such as laboratory products, pharmaceuticals, vaccines, surgical products, dental specialty products and diagnostic tests. This segment, which accounts for 93.5% of net sales, is sub-divided between dental (61.1% of total net sales) and medical... Kenneth SquireCassava Sciences (NASDAQ:SAVA) Shares Gap Down – Here’s Why$10M Registered Direct Offering Priced At-The-Market Under Nasdaq Rules